Canaccord raised the firm’s price target on UiPath (PATH) to $19 from $15 and keeps a Buy rating on the shares. The firm said the company demonstrated improving execution and continued signs of building momentum selling agentic capabilities in its FQ3’26. It was the first quarter in two years that net-new ARR has increased on a year-over-year basis, marking a significant milestone that gives credence to the company’s strategy leaning into agentic automation and orchestration in a dynamic enterprise software market.
Claim 55% Off TipRanks
Forget margin or options. Here's how the pros trade PATHPublished first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PATH:
- UiPath price target raised to $14 from $12 at Wells Fargo
- Cautious Optimism for UiPath: Strong Q3 Results Amid Uncertainty
- UiPath: Balancing Strong Q3 Performance with Early-Stage AI Monetization and Profitability Concerns
- UiPath Inc. Reports Strong Q3 2026 Performance
- UiPath’s Balanced Outlook: Improved Execution Amid Market Uncertainties